Signaling Pathways - NPY Receptors - Angiotensin AT1 Receptors - Trypsinogen - Insulin and Insulin-like Receptors
清除全部
-
B7155 BIBP 3226 trifluoroacetateTarget: NPY Receptors|NPFF receptorSummary: 混合NPY Y1和NPFF受体拮抗剂 -
B2214 Valsartan中文名: 缬沙坦Target: Angiotensin AT1 ReceptorsSummary: 血管紧张素II AT1受体拮抗剂 -
B1007 AVE 09911 CitationTarget: Angiotensin AT1 ReceptorsSummary: 血管紧张素-（1-7）受体激动剂 -
B2210 Azilsartan中文名: 阿齐沙坦Target: Angiotensin AT1 ReceptorsSummary: 强效血管紧张素II 1型（AT1）受体反向激动剂 -
A8440 GSK1838705ATarget: Insulin and Insulin-like Receptors|ALKSummary: ATP竞争性IGF-IR/IR/ALK抑制剂 -
A5970 Irbesartan中文名: 安博维，厄贝沙坦Target: Angiotensin AT1 ReceptorsSummary: 血管紧张素II抑制剂 -
A1302 GSK1904529ATarget: Insulin and Insulin-like ReceptorsSummary: IGF-1R/IR 选择性抑制剂 -
A1185 BMS-754807Target: Insulin and Insulin-like ReceptorsSummary: 有效的、选择性的IGF-1R和InsR抑制剂 -
A3608 MK 0893Target: Insulin and Insulin-like Receptors|Glucagon ReceptorsSummary: 胰高血糖素受体/ IGF-1R拮抗剂 -
A4302 Rosiglitazone maleate中文名: 马来酸罗格列酮Target: Insulin and Insulin-like ReceptorsSummary: PPARγ激动剂，有效的胰岛素敏化剂